ATHENA (GOG-3020/ENGOT-ov45): a randomized, phase III trial to evaluate rucaparib as monotherapy (ATHENA–MONO) and rucaparib in combination with nivolumab (ATHENA–COMBO) as maintenance treatment following frontline platinum-based chemotherapy in ovarian cancer
Title:
ATHENA (GOG-3020/ENGOT-ov45): a randomized, phase III trial to evaluate rucaparib as monotherapy (ATHENA–MONO) and rucaparib in combination with nivolumab (ATHENA–COMBO) as maintenance treatment following frontline platinum-based chemotherapy in ovarian cancer
Author:
Monk, Bradley J Coleman, Robert L Fujiwara, Keiichi Wilson, Michelle K Oza, Amit M Oaknin, Ana O’Malley, David M Lorusso, Domenica Westin, Shannon N Safra, Tamar Herzog, Thomas J Marmé, Frederik N Eskander, Ramez Lin, Kevin K Shih, Danny Goble, Sandra Grechko, Nikolay Hume, Stephanie Maloney, Lara McNeish, Iain A Kristeleit, Rebecca S
Appeared in:
International journal of gynecological cancer
Paging:
Volume 31 () nr. 12 pages p.
Year:
2021
Contents:
Publisher:
IGCS and ESGO 2021. Re-use permitted under CC BY-NC. No commercial re-use. Published by BMJ.